These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3319599)

  • 1. Acromegaly.
    Baumann G
    Endocrinol Metab Clin North Am; 1987 Sep; 16(3):685-703. PubMed ID: 3319599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective analysis of 151 cases of patients with acromegaly operated by one neurosurgeon: a follow-up of more than 23 years.
    Abbassioun K; Amirjamshidi M; Mehrazin A; Khalatbary I; Keynama M; Bokai H; Abdollahi M
    Surg Neurol; 2006 Jul; 66(1):26-31; discussion 31. PubMed ID: 16793431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines for the diagnosis and treatment of acromegaly: a Canadian perspective.
    Patel YC; Ezzat S; Chik CL; Rorstad OP; Serri O; Ur E; Wilkins GE
    Clin Invest Med; 2000 Jun; 23(3):172-87. PubMed ID: 10911548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas.
    Minniti G; Jaffrain-Rea ML; Osti M; Esposito V; Santoro A; Solda F; Gargiulo P; Tamburrano G; Enrici RM
    Clin Endocrinol (Oxf); 2005 Feb; 62(2):210-6. PubMed ID: 15670198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal diagnosis of GH hypersecretory states.
    Grottoli S; Gasco V; Ragazzoni F; Ghigo E
    J Endocrinol Invest; 2003; 26(10 Suppl):27-35. PubMed ID: 15497657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decrease in growth hormone and insulin-like growth factor (IGF)-1 release and amelioration of acromegaly features after rosiglitazone treatment of type 2 diabetes mellitus a patient with acromegaly.
    Gradiser M; Matovinovic M; Vrkljan M
    Croat Med J; 2007 Feb; 48(1):87-91. PubMed ID: 17309144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acromegaly--diagnosis and treatment].
    Bollerslev J
    Tidsskr Nor Laegeforen; 2000 Sep; 120(21):2534-8. PubMed ID: 11070991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The PPAR-gamma activator rosiglitazone fails to lower plasma growth hormone and insulin-like growth factor-1 levels in patients with acromegaly.
    Bastemir M; Akin F; Yaylali GF
    Neuroendocrinology; 2007; 86(2):119-23. PubMed ID: 17671378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The treatment of acromegaly].
    Beauregard H; Somma M; Rasio E; Serri O; Aris-Jilwan N; Comtois R; Long H; Abribat T; Boucher A; Hardy J
    Union Med Can; 1993; 122(6):489-95. PubMed ID: 8303792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary tumours: acromegaly.
    Chanson P; Salenave S; Kamenicky P; Cazabat L; Young J
    Best Pract Res Clin Endocrinol Metab; 2009 Oct; 23(5):555-74. PubMed ID: 19945023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acromegaly].
    Morange I; Jaquet P
    Rev Prat; 1996 Jun; 46(12):1482-5. PubMed ID: 8881161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatomedin-C in active and successfully treated acromegaly.
    Knappe G; Hesse V; Jahreis G; Rohde W; Gerl H
    Exp Clin Endocrinol; 1988 Mar; 91(1):2-6. PubMed ID: 3371416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure?
    Damjanovic SS; Neskovic AN; Petakov MS; Popovic V; Macut D; Vukojevic P; Joksimovic MM
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):410-7. PubMed ID: 15807870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acromegaly: unravelling a complex disease.
    O'Halloran DJ; Shalet SM
    Growth Regul; 1995 Sep; 5(3):119-24. PubMed ID: 7580862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homocysteine levels in acromegaly patients.
    Hekimsoy Z; Ozmen B; Ulusoy S
    Neuro Endocrinol Lett; 2005 Dec; 26(6):811-4. PubMed ID: 16380700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic testing in the diagnosis and follow-up of patients with acromegaly.
    Wass JA
    J Endocrinol Invest; 2003; 26(7 Suppl):48-53. PubMed ID: 14604066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presurgical octreotide treatment in acromegaly: no improvement of final growth hormone (GH) concentration and pituitary function. A long-term case-control study.
    Plöckinger U; Quabbe HJ
    Acta Neurochir (Wien); 2005 May; 147(5):485-93; discussion 493. PubMed ID: 15806331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gamma knife radiosurgery for acromegaly--long-term experience.
    Jezková J; Marek J; Hána V; Krsek M; Weiss V; Vladyka V; Lisák R; Vymazal J; Pecen L
    Clin Endocrinol (Oxf); 2006 May; 64(5):588-95. PubMed ID: 16649981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of persistent and recurrent acromegaly.
    Del Porto LA; Liubinas SV; Kaye AH
    J Clin Neurosci; 2011 Feb; 18(2):181-90. PubMed ID: 21167718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.